Resumen

RIBEIRO, Catarina Isabel et al. Atheroembolic renal disease and rivaroxaban: A new association. Port J Nephrol Hypert [online]. 2020, vol.34, n.2, pp.119-121. ISSN 0872-0169.  https://doi.org/10.32932/pjnh.2020.07.078.

Atheroembolic renal disease is a multisystem clinical entity of unknown incidence. It is often associated with severe atherosclerotic disease and its etiology can be spontaneous or iatrogenic. Its pathophysiology is based on renal dysfunction secondary to embolization of cholesterol crystals, followed by occlusive phenomena affecting the renal vasculature. The present report describes the case of a patient with several cardiovascular risk factors, with a recent introduction of rivaroxaban. The clinical course presented was suggestive of renal atheroembolic disease, and the histological evaluation corroborated this diagnosis.

Palabras clave : Acute Kidney Injury; Atheroembolic renal disease; Rivaroxaban.

        · texto en Inglés     · Inglés ( pdf )